MGH Summary of screen methodology.docx

syn2731489

Created By Roberta Beauchamp Beauchamp

assay: cellViabilityAssay
species: Human
cellType: meningioma,CRISPR arachnoid
dataType: drugScreen
diagnosis: Neurofibromatosis 2
tumorType: Meningioma
consortium: Synodos
fileFormat: doc
isCellLine: TRUE
specimenID: Syn2,Syn4,Syn6
dataSubtype: report
nf1Genotype: unknown
nf2Genotype: +/+,-/-
individualID: Syn2,Syn4,Syn6
resourceType: experimentalData
fundingAgency: CTF
isPrimaryCell: FALSE
timePointUnit: hours
drugScreenType: singleMolecule
isMultiSpecimen: TRUE
isMultiIndividual: TRUE
cellLineMetadataSynId: syn3275123
experimentalCondition: Axitinib,Selumetinib,Bortezomib,Lapatanib,Panobinostat,Vorinostat,GDC-0941,Vismodegib,OSU-03012,Everolimus,Ganetespib,LY2157299,AR-42,GSK2126458,Trametinib,GDC-0980,CUDC907,AZD2014,Perifosine,DMSO,media
specimenMetadataSynId: syn5569975

MGH Summary of screen methodology.docx page is loading…